Protocollo di studio

Coordinatore di Long-Term pegylated alpha 2b interferon therapy of patients with hepatitis C- related cirrhosis and high liver cell proliferation: a multicenterr study of hepatocellular carcinoma prevention in patients non-responders to combined therapy with alpha interferon + ribavirin or Peginterferon alpha + Ribavirin or to interferon monotherapy(2001 Apr 23).

Coordinatore di Long-Term pegylated alpha 2b interferon therapy of patients with hepatitis C- related cirrhosis and high liver cell proliferation: a multicenterr study of hepatocellular carcinoma prevention in patients non-responders to combined therapy with alpha interferon + ribavirin or Peginterferon alpha + Ribavirin or to interferon monotherapy

2001

Abstract

Protocollo di studio
Ospedale Maggiore Policlinico, Mangiagalli e Regina Elena, Fondazione IRCCS
Schering-Plough S.p.A, MDS Pharma Services Italia
Activity
Coordinatore di Long-Term pegylated alpha 2b interferon therapy of patients with hepatitis C- related cirrhosis and high liver cell proliferation: a multicenterr study of hepatocellular carcinoma prevention in patients non-responders to combined therapy with alpha interferon + ribavirin or Peginterferon alpha + Ribavirin or to interferon monotherapy(2001 Apr 23).
File in questo prodotto:
Non ci sono file associati a questo prodotto.
Pubblicazioni consigliate

I documenti in IRIS sono protetti da copyright e tutti i diritti sono riservati, salvo diversa indicazione.

Utilizza questo identificativo per citare o creare un link a questo documento: https://hdl.handle.net/2434/33908
Citazioni
  • ???jsp.display-item.citation.pmc??? ND
  • Scopus ND
  • ???jsp.display-item.citation.isi??? ND
social impact